ShadowBuys
Sign inJoin for free
Committee overlap: Energy and Commerce

Rep. Thomas H. Kean, Jr. sold Stryker (SYK)

Rep. Thomas H. Kean, Jr. (R-NJ-7) · $15K–$50K · traded Feb 26, 2025

Why this is a committee overlap

Kean is a member of the House Committee on Energy and Commerce, which oversees the Healthcare sector. Stryker is classified in the Medical - Devices industry.

An overlap is a fact about the trade, not evidence of wrongdoing. Committee assignments are current ones.

Transaction
Sold (partial)
Amount
$15K–$50K
Owner
Not stated
Traded
Feb 26, 2025
Disclosed
Mar 14, 2025
Days to disclose
16
Asset type
Stock
As filed
Stryker Corporation Common Stock
Industry
Medical - Devices · Healthcare
Official filing ↗All of Kean's tradesAll Congress trades in SYK

Other trades in this filing

Recent Congress trades in SYK

Company context for SYK

Recent records for the company. These may have been published before or after this trade; compare the dates before drawing a connection.

  1. SYKContract award·USAspending

    SYK: Department of Health and Human Services contract award

    STRYKER CORPORATION:1232894 [18-009009]

    First observed: Nov 8, 2026, 3:57 PM ESTEvent / period: Apr 10, 2018Original source ↗

    1 congressional household disclosed purchases in the past 90 days. See the trades

  2. SYKContract award·USAspending

    SYK: Department of Health and Human Services contract award

    STRYKER CORPORATION:1232894 [18-010124]

    First observed: Nov 8, 2026, 3:57 PM ESTEvent / period: May 21, 2018Original source ↗

    1 congressional household disclosed purchases in the past 90 days. See the trades

  3. SYKContract award·USAspending

    SYK: Department of Health and Human Services contract award

    STRYKER CORPORATION:1232894 [17-014454]

    First observed: Nov 8, 2026, 3:57 PM ESTEvent / period: Aug 2, 2017Original source ↗

    1 congressional household disclosed purchases in the past 90 days. See the trades

From a periodic transaction report filed under the STOCK Act. Amounts are the ranges members report. Nothing here is investment advice.